This inventor holds 1 USPTO granted patent. Top assignees: Korea Research Institute of Chemical Technology, Yungjin Pharmaceuticals Co., Ltd.. Active years: 2006.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 651 
1 out of 1 Years Active: 2006
Title: Yoon Sung Jung: Innovator in Pharmaceutical Chemistry
Introduction
Yoon Sung Jung is a notable inventor based in Gyeonggi-do, South Korea. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that target specific biological pathways.
Latest Patents
Yoon Sung Jung holds a patent for "Quinoline derivatives as caspase-3 inhibitor, preparation for producing the same and pharmaceutical composition comprising the same." This invention relates to new quinoline derivatives that exhibit caspase-3 inhibitory activity. The patent outlines methods for preparing these compounds and their potential use in treating caspase-associated diseases.
Career Highlights
Throughout his career, Yoon Sung Jung has worked with prominent organizations, including Yungjin Pharmaceuticals Co., Ltd. and the Korea Research Institute of Chemical Technology. His work has focused on the synthesis and application of novel pharmaceutical compounds.
Collaborations
Yoon has collaborated with several professionals in his field, including Sung-Gyu Kim and Jae Yang Kong. These collaborations have contributed to the advancement of research in pharmaceutical applications.
Conclusion
Yoon Sung Jung's innovative work in developing quinoline derivatives showcases his commitment to advancing pharmaceutical science. His contributions have the potential to impact the treatment of various diseases significantly.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile